Molecular mimicry in multiple sclerosis

References

• Fujinami RS, Oldstone MBA, Wroblewska Z, Frankel ME, Koprowski H. Molecular mimicry in virus infection: Crossreaction of measles virus phosphoprotein or of herpes simplex virus protein with human intermediate filaments. Proc Natl Acad Sci USA 1983; 80: 2346–2350
   PubMed Web of Science ®Google Scholar
• Abromson-Leeman SR, Cantor H. Specificity of T cell clones for antigen and autologous major histocompatibility complex products determines specificity for foreign major histocompatibility complex products. J Exp Med 1983; 158: 428–437
   Google Scholar
• Fujinami RS, Oldstone MBA. Amino acid homology between the encephalitogenic site of myelin basic protein and virus: Mechanism for autoimmunity. Science 1985; 230: 1043–1045
   PubMed Web of Science ®Google Scholar
• Dyrberg T, Oldstone MBA. Peptides as probes to study molecular mimicry and virus-induced autoimmunity. Curr Top Microbiol Immunol 1986; 130: 25–37
   PubMedGoogle Scholar
• Schwimmbeck PL, Yu DT, Oldstone MBA. Autoantibodies to HLA B27 in the sera of HLA B27 patients with ankylosing spondylitis and Reiter's syndrome. Molecular mimicry with Klebsiella pneumoniae as potential mechanism of autoimmune disease. J Exp Med 1987; 166: 173–181
   PubMed Web of Science ®Google Scholar
• Benoist C, Mathis D. Autoimmunity provoked by infection: How good is the case for T cell epitope mimicry?. Nat Immunol 2001; 9: 797–801
   Google Scholar
• Regner M, Lambert PH. Autoimmunity through infection or immunization?. Nat Immunol 2001; 2: 185–188
   Google Scholar
• Wraith DC, Goldman M, Lambert PH. Vaccination and autoimmune disease: What is the evidence?. Lancet 2003; 362: 1659–1666
   PubMed Web of Science ®Google Scholar
• Townsend AR, Rothbard J, Gotch FM, Bahadur G, Wraith D, McMichael AJ. The epitopes of influenza nucleoprotein recognized by cytotoxic T lymphocytes can be defined with short synthetic peptides. Cell 1986; 44: 959–968
   PubMed Web of Science ®Google Scholar
• Mason D. A very high level of crossreactivity is an essential feature of the T-cell receptor. Immunol Today 1998; 19: 395–404
   PubMedGoogle Scholar
• Hemmer B, Fleckenstein B, Vergelli M, Jung G, McFarland HF, Martin R, WiesmŸller K-H. Identification of high potency microbial and self ligands for a human autoreactive class II-restricted T cell clone. J Exp Med 1997; 185: 1651–1659
   PubMed Web of Science ®Google Scholar
• Garboczi DN, Ghosh P, Utz U, Fan QR, Biddison WE, Wiley DC. Structure of the complex between human T-cell receptor, viral peptide and HLA-A2. Nature 1996; 384: 134–141
   PubMed Web of Science ®Google Scholar
• Wucherpfennig KW, Strominger JL. Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein. Cell 1995; 80: 695–705
   PubMed Web of Science ®Google Scholar
• Evavold BD, Sloan-Lancaster J, Wilson KJ, Rothbard JB, Allen PM. Specific T cell recognition of minimally homologous peptides: Evidence for multiple endogenous ligands. Immunity 1995; 6: 655–663
   Google Scholar
• Hemmer B, Vergelli M, Gran B, Ling N, Conlon P, Pinilla C, Houghten R, McFarland HF, Martin R. Predictable TCR antigen recognition based on peptide scans leads to the identification of agonist ligands with no sequence homology. J Immunol 1998; 160: 3631–3636
   PubMed Web of Science ®Google Scholar
• Hemmer B, Pinilla C, Gran B, Vergelli M, Ling N, Conlon P, McFarland HF, Houghten R, Martin R. Contribution of individual amino acids within MHC molecule or antigenic peptide to TCR ligand potency. J Immunol 2000; 164: 861–871
   PubMed Web of Science ®Google Scholar
• Lang HL, Jacobsen H, Ikemizu S, Andersson C, Harlos K, Madsen L, Hjorth P, Sondergaard L, Svejgaard A, Wucherpfennig K, Stuart DI, Bell JI, Jones EY, Fugger L. A functional and structural basis for TCR cross-reactivity in multiple sclerosis. Nat Immunol 2002; 3: 940–943
   PubMed Web of Science ®Google Scholar
• Sospedra M, Muraro PA, Stefanova I, Zhao Y, Chung K, Li Y, Giulianotti M, Simon R, Mariuzza R, Pinilla C, Martin R. Redundancy in antigen presenting function of the HLA-DR and -DQ molecules in the multiple sclerosis-associated HLA-DR15 haplotype. J Immunol 2005, in press
   Google Scholar
• Fourneau JM, Bach JM, van Endert PM, Bach JF. The elusive case for a role of mimicry in autoimmune diseases. Mol Immunol 2004; 40: 1095–1102
   PubMedGoogle Scholar
• Kriesel JD, Sibley WA. The case for rhinoviruses in the pathogenesis of multiple sclerosis. Mult Scler 2005; 11: 1–4
   PubMed Web of Science ®Google Scholar
• Challoner PB, Smith KT, Parker JD, MacLeod DL, Coulter SN, Rose TM, Schultz ER, Bennett JL, Garber RL, Chang M, Schad PA, Stewart PM, Nowinski RC, Brown JP, Burmer GC. Plaque-associated expression of human herpesvirus 6 in multiple sclerosis. Proc Natl Acad Sci USA 1995; 92: 7440–7444
   PubMed Web of Science ®Google Scholar
• Soldan SS, Berti R, Salem N, Secchiero P, Flamand L, Calabresi PA, Brennan MB, Maloni HW, McFarland HF, Lin HC, Patnaik M, Jacobson S. Association of human herpes virus 6 (HHV-6) with multiple sclerosis: Increased IgM response to HHV-6 early antigen and detection of serum HHV-6 DNA. Nat Med 1997; 3: 1394–1397
   PubMed Web of Science ®Google Scholar
• Tejada-Simon MV, Zang YC, Hong J, Rivera VM, Zhang JZ. Cross-reactivity with myelin basic protein and human herpesvirus-6 in multiple sclerosis. Ann Neurol 2003; 53: 189–197
   PubMed Web of Science ®Google Scholar
• Wandinger K, Jabs W, Siekhaus A, Bubel S, Trillenberg P, Wagner H, Wessel K, Kirchner H, Hennig H. Association between clinical disease activity and Epstein–Barr virus reactivation in MS. Neurology 2000; 55: 178–184
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernan MA, Olek MJ, Hankinson SE, Hunter DJ. Epstein-Barr virus antibodies and risk of multiple sclerosis: A prospective study. JAMA 2001; 286: 3083–3088
   PubMed Web of Science ®Google Scholar
• Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Bussow K, Sommer N, Hemmer B. Identification of Epstein–Barr virus proteins as putative targets of the immune response in multiple sclerosis. J Clin Investig 2005; 115: 1352–1360
   PubMed Web of Science ®Google Scholar
• Holmoy T, Kvale EO, Vartdal F. Cerebrospinal fluid CD4+T cells from a multiple sclerosis patient cross-recognize Epstein–Barr virus and myelin basic protein. J Neurovirol 2004; 10: 278–283
   PubMed Web of Science ®Google Scholar
• Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A. Temporal relationship between elevation of Epstein–Barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. JAMA 2005; 293: 2496–2500
   PubMed Web of Science ®Google Scholar
• Ufret-Vincenty RL, Quigley L, Tresser N, Pak SH, Gado A, Hausmann S, Wucherpfennig KW, Brocke S. In vivo survival of viral antigen-specific T cells that induce experimental autoimmune encephalomyelitis. J Exp Med 1988; 188: 1725–1738
   Google Scholar
• Madsen LS, Andersson EC, Jansson L, Krogsgaard M, Andersen CB, Engberg J, Strominger JL, Svejgaard A, Hjorth JP, Holmdahl R, Wucherpfennig KW, Fugger L. A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor. Nat Genet 1999; 23: 343–347
   PubMed Web of Science ®Google Scholar
• Quandt JA, Baig M, Yao K, Kawamura K, Huh J, Ludwin SK, Bian HJ, Bryant M, Quigley L, Nagy ZA, McFarland HF, Muraro PA, Martin R, Ito K. Unique clinical and pathological features in HLA-DRB1*0401-restricted MBP 111-129-specific humanized TCR transgenic mice. J Exp Med 2004; 200: 223–234
   PubMed Web of Science ®Google Scholar
• Croxford JL, Anger HA, Miller SD. Viral delivery of an epitope from Haemophilus influenzae induces central nervous system autoimmune disease by molecular mimicry. J Immunol 2005; 174: 907–917
   PubMed Web of Science ®Google Scholar
• Croxford JL, Olson JK, Anger HA, Miller SD. Initiation and exacerbation of autoimmune demyelination of the central nervous system via virus-induced molecular mimicry: Implications for the pathogenesis of multiple sclerosis. J Virol 2005; 79: 8581–8590
   PubMed Web of Science ®Google Scholar
• Fujinami RS. Molecular mimicry that primes for autoimmunity which is triggered by infection. Mol Psychiatry 2002; 2(7)S32–S33
   Google Scholar
• Sospedra M, Zhao Y, Zur Hausen H, Muraro PA, Hamashin C, de Villiers E-M, Pinilla C, Martin R. Recognition of conserved amino acid motifs of common viruses and its role in autoimmunity. PLoS Pathogens 2005, in press
   Google Scholar
• Olson JK, Croxford JL, Calenoff MA, Dal Canto MC, Miller SD. A virus-induced molecular mimicry model of multiple sclerosis. J Clin Investig 2001; 108: 311–318
   PubMed Web of Science ®Google Scholar